Ljubljana, Slovenia

Samo Andrensek

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samo Andrensek. Retrieved from https://idiyas.com/inventor/samo-andrensek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Samo Andrensek: Innovator in Organic Chemistry

Introduction

Samo Andrensek is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of organic chemistry, particularly in the synthesis of pharmaceutical compounds. His work has led to the development of innovative processes that are essential for the preparation of important medications.

Latest Patents

Samo Andrensek holds a patent for "Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof." This invention focuses on a process for preparing specific chemical compounds that serve as key intermediates in the synthesis of rosuvastatin, a medication used to lower cholesterol levels.

Career Highlights

Samo Andrensek is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His expertise in organic chemistry has been instrumental in advancing the company's research and development efforts. With a total of 1 patent, he has established himself as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Samo has collaborated with talented colleagues, including Jolanda Anzel and Marjeta Hocevar. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Samo Andrensek's contributions to organic chemistry and his innovative patent work highlight his importance in the pharmaceutical field. His dedication to advancing medical science through research and collaboration continues to make a significant impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…